Chairman Towns Invites FDA to Johnson & Johnson Hearing |
Chairman Towns Invites FDA to Johnson & Johnson Hearing Requests testimony from Principal Deputy Commissioner Sharfstein for second J&J hearing on circumstances surrounding pediatric, "phantom” recalls; wants all FDA records related to J&J’s “phantom recall” of Motrin
WASHINGTON – Chairman Edolphus "Ed" Towns (D-NY) today invited Food and Drug Administration (FDA) Principal Deputy Commissioner Dr. Joshua Sharfstein to testify during a committee hearing on Thursday, September 30, 2010, that will examine the circumstances surrounding Johnson & Johnson’s recall of over 135 million bottles of infant and children’s medicines produced by Johnson & Johnson/McNeil Consumer Healthcare, including such widely used products as Children’s Tylenol, Infant’s Tylenol, Children’s Motrin, and Children’s Benadryl. The hearing will also examine the circumstances surrounding the "phantom recall" of a particular Motrin product, which became public as a result of the Committee’s hearing on May 27, 2010.
Principal Deputy Commissioner U.S. Food and Drug Administration
Chairman and Chief Executive Officer Johnson & Johnson
Worldwide Chairman, Consumer Group Johnson & Johnson
### Documents and Links |
Committee On Oversight and Government Reform
U.S. House of Representatives | 2157 Rayburn House Office Building | Washington, D.C. 20515 | (202) 225-5051